TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05257551: Tempus Small Cell Lung Cancer Observational Study (Sculptor)

Sponsor: Tempus AI · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 200 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$11,180,400

Rescue Site Savings

+$7,392,000

Unlock Full NCT05257551 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05257551 Rescue Dossier →